The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

William E. Boden

University of Connecticut School of Medicine

Farmington

USA

[email]@harthosp.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Connecticut School of Medicine, Farmington, USA. 2006
  • VA Connecticut Healthcare System, West Haven, USA. 2006
  • Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, USA. 2001 - 2004
  • The Heart Center at Hartford Hospital, Hartford, Connecticut 06112, USA. 2001 - 2003
  • Hartford Hospital, 80 Seymour Street, CT 06102, USA. 2002
  • Veterans Affairs Medical Center, Syracuse, New York, USA. 2000

References

  1. What is the optimum role and timing of early invasive management of patients with acute coronary syndromes?. Boden, W.E. Nature Clinical Practice. Cardiovascular Medicine (2006) [Pubmed]
  2. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. Boden, W.E., O'rourke, R.A., Teo, K.K., Hartigan, P.M., Maron, D.J., Kostuk, W., Knudtson, M., Dada, M., Casperson, P., Harris, C.L., Spertus, J.A., Shaw, L., Chaitman, B.R., Mancini, G.B., Berman, D.S., Weintraub, W.S. Am. Heart J. (2006) [Pubmed]
  3. The origins and development of the Cardiovascular Program at Hartford Hospital. 150th Anniversary of Hartford Hospital. Boden, W.E., Phinney, A.O., Low, H.B., Kluger, J., McLean, C., Shapiro, R., Hammond, J., Kiernan, F.J., Humphrey, C., Rossi, M.A., Fieldman, A., McKay, R.G., Gillam, L.D., Clyne, C.A., Heller, G.V., Thompson, P.D. Conn. Med (2004) [Pubmed]
  4. "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. Boden, W.E. J. Am. Coll. Cardiol. (2003) [Pubmed]
  5. Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management. Boden, W.E. Curr. Opin. Cardiol. (2003) [Pubmed]
  6. The role of pharmacotherapy and catheter-based intervention in the management of patients with non-ST-segment elevation acute coronary syndromes. Boden, W.E. Curr. Cardiol. Rep (2002) [Pubmed]
  7. Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes. Boden, W.E. Am. J. Cardiol. (2001) [Pubmed]
  8. Defining the optimal pharmacotherapy of non-ST-segment elevation (NSTE) acute coronary syndromes (ACS): a rapidly moving target. Boden, W.E. Curr. Opin. Cardiol. (2001) [Pubmed]
  9. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Boden, W.E., van Gilst, W.H., Scheldewaert, R.G., Starkey, I.R., Carlier, M.F., Julian, D.G., Whitehead, A., Bertrand, M.E., Col, J.J., Pedersen, O.L., Lie, K.I., Santoni, J.P., Fox, K.M. Lancet (2000) [Pubmed]
 
WikiGenes - Universities